EC
IONS icon

EntryPoint Capital’s Ionis Pharmaceuticals IONS Stock Holding History

EntryPoint Capital’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$222K Buy
+2,963
New +$234K 0.07% 599
2025
Q4 		– Sell
-3,458
Closed -$226K – 759
2025
Q3 		$226K Buy
+3,458
New +$169K 0.09% 499
2025
Q1 		– Sell
-6,382
Closed -$223K – 799
2024
Q4 		$223K Buy
+6,382
New +$239K 0.09% 538
2024
Q2 		– Sell
-76
Closed -$3.29K – 1247
2024
Q1 		$3.29K Sell
76
-802
-91% -$38.2K ﹤0.01% 1326
2023
Q4 		$44.4K Buy
+878
New +$42.1K 0.04% 786

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return